Loading
Latest filing published 11 Dec 2025 for Evommune, Inc., €23k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Eugene Bauer is a declared insider at 2 companies (board member); the most frequent names are Kadmon Holdings, Inc. and Evommune, Inc. The record holds 5 filings, for trades running from 8 August 2017 to 9 December 2025.
On the market, this insider has only ever bought: 1 purchase, €10k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 1 share grant.
Most recently, on 11 December 2025, the filings show a share grant worth €23k in Evommune, Inc. The most recent open-market purchase was published on 8 August 2017, 3,366 days ago. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations